• Shumei Man, Muhammad Shazam Hussain, Dolora Wisco, Irene L Katzan, Junya Aoki, Yohei Tateishi, Esteban Cheng-Ching, Ferdinand K Hui, Thomas J Masaryk, Peter A Rasmussen, and Ken Uchino.
• Cerebrovascular Center, Neurological Institute, Cleveland Clinic, Cleveland, OH.
• J Neuroimaging. 2015 Mar 1;25(2):263-8.

Background And PurposeIntraarterial (IA) mechanical thrombectomy has an excellent recanalization rate but does not always correlate with good clinical outcomes. We aimed to investigate whether hyperdense middle cerebral artery sign (HMCAS) on preintervention nonenhanced CT (NECT) predicts IA therapy outcome for acute stroke.MethodsData were abstracted from our Hyperacute Ischemic Stroke database. Patients with occlusion in ICA, MCA, or MCA M2 branches who underwent IA therapy were included.ResultsAmong 126 patients who underwent IA treatment, 64 (51%) had hyperdense M1 MCA sign (M1 HMCAS), 11 (9%) had hyperdense M2, and 51 (40%) had No HMCAS (NHMCAS).M1 HMCAS and NHMCAS group has comparable baseline stroke severity and infarct volume (P > .05); and the differences of favorable outcome (modified Rankin Score 0-2) at 30 days were not significant (21% vs. 30%, P = .259). For those with HMCAS, favorable 30-day outcome was most frequent in Distal HMCAS (39%), followed by hyperdense M2 (27%), HMCAS proximal (11%), and HMCAS full length (0%).ConclusionsFor acute ischemic stroke due to large vessel occlusion, the lack of HMCAS on NECT does not predict favorable outcome after IA therapy. Among those with HMCAS, proximal and longer HMCAS predicts unfavorable outcome.Copyright © 2014 by the American Society of Neuroimaging.

28 keywords...

hide…